Unknown

Dataset Information

0

Influence of Individual Radiosensitivity on the Adaptive Response Phenomenon: Toward a Mechanistic Explanation Based on the Nucleo-Shuttling of ATM Protein.


ABSTRACT: The adaptive response (AR) phenomenon generally describes a protective effect caused by a "priming" low dose (dAR) delivered after a period of time (?tAR) before a higher "challenging" dose (DAR). The AR is currently observed in human cells if dAR, ?tAR, and DAR belong to (0.001-0.5 Gy), (2-24 hours), (0.1-5 Gy), respectively. In order to investigate the molecular mechanisms specific to AR in human cells, we have systematically reviewed the experimental AR protocols, the cellular models, and the biological endpoints used from the 1980s. The AR appears to be preferentially observed in radiosensitive cells and is strongly dependent on individual radiosensitivity. To date, the model of the nucleo-shuttling of the ATM protein provides a relevant mechanistic explanation of the AR molecular and cellular events. Indeed, the priming dose dAR may result in the diffusion of a significant amount of active ATM monomers in the nucleus. These ATM monomers, added to those induced directly by the challenging dose DAR, may increase the efficiency of the response to DAR by a better ATM-dependent DNA damage recognition. Such mechanistic model would also explain why AR is not observed in radioresistant or hyperradiosensitive cells. Further investigations at low dose are needed to consolidate our hypotheses.

SUBMITTER: Devic C 

PROVIDER: S-EPMC6081762 | biostudies-literature | 2018 Jul-Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Influence of Individual Radiosensitivity on the Adaptive Response Phenomenon: Toward a Mechanistic Explanation Based on the Nucleo-Shuttling of ATM Protein.

Devic Clément C   Ferlazzo Mélanie L ML   Foray Nicolas N  

Dose-response : a publication of International Hormesis Society 20180701 3


The adaptive response (AR) phenomenon generally describes a protective effect caused by a "priming" low dose (<i>d</i><sub>AR</sub>) delivered after a period of time (Δ<i>t</i><sub>AR</sub>) before a higher "challenging" dose (<i>D</i><sub>AR</sub>). The AR is currently observed in human cells if <i>d</i><sub>AR</sub>, Δ<i>t</i><sub>AR</sub>, and <i>D</i><sub>AR</sub> belong to (0.001-0.5 Gy), (2-24 hours), (0.1-5 Gy), respectively. In order to investigate the molecular mechanisms specific to AR  ...[more]

Similar Datasets

2018-09-11 | GSE99584 | GEO
| S-EPMC1876774 | biostudies-literature
| S-EPMC4537249 | biostudies-literature
| S-EPMC5519549 | biostudies-literature
| S-EPMC10443976 | biostudies-literature
| S-EPMC10390303 | biostudies-literature
| S-EPMC7038028 | biostudies-literature
| S-EPMC8352595 | biostudies-literature
| S-EPMC5431775 | biostudies-literature
| S-EPMC1276963 | biostudies-other